April 2018 - IOZK

Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

2018-04-26/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2018-04-26 / Front Oncol 2018;8:127

Immunotherapy of Hepatocellular Carcinoma

2018-04-20/in Checkpoint-Inhibitors, Dendritic Cells, Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2018-04-20 / Oncol Res Treat 2018;41(5):292-297

IOZK Vortrag über die Effekte der multimodalen Immuntherapie bei einem Ponsgliom mit Hilfe der Analysemethode Flüssigbiopsie.

2018-04-11/0 Kommentare/in Externe Meldungen, IOZK bei Fachtagungen /von root

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

2018-04-11/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-04-11 / Sci Transl Med 2018 Apr;10(436)

Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model

2018-04-05/in International Publications, Newcastle Disease Virus /von 2018-04-05 / PLoS ONE 2018;13(4):e0195425

Newcastle disease virus strain AF2240 as an oncolytic virus: A review

2018-04-04/in International Publications, Newcastle Disease Virus /von 2018-04-04 / Acta Trop. 2018 Jul;183:126-133

Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial

2018-04-01/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2018-04-01 / JAMA Oncol 2018 Apr;4(4):483-492

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study

2018-04-01/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2018-04-01 / Anticancer Res. 2018 04;38(4):2217-2225